REGIONAL DIFFERENCES IN THE ORGANIZATION OF ACCESS TO HIGH-COST DRUGS IN BRAZILIAN STATES
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: LEITE, Silvana (Universidade Federal De Santa Catarina, Pharmaceutical Sciences, Itajai, Brazil)
- Co-author(s): Silvana Nair Leite
In Brazil, the Specialised Component of Pharmaceutical Assistance (SCPA) is a program for the supply of high-cost medicines. It receives from the government an annual investment of about US$ 2,13 billion aiming to ensure the completeness of treatments based on Clinical Protocols and Therapeutic Guidelines (CPTG) that clearly establish criteria.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.